BeyondSpring Pharma (BYSI) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan
The financial position of BeyondSpring Inc. (BYSI) is under pressure due to stringent regulatory requirements and the risks of repeat trials. Cancer drug development here is accelerating through AI and synthesis automation, although physicians remain indispensable in clinics. The company's price chart shows an EV/EBITDA of 0.00, while the business relies on an asset-light model with outsourced production to optimize research costs.
BYSI (beyondspringpharma.com): rincian analitis lan laporan miturut indikator
- rega saham lan target rega konsensus:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data utang lan likuiditas:
Utang marang Ekuitas BeyondSpring Inc.|BYSI - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas BeyondSpring|BYSI - Utang perusahaan|Rasio utang marang kapitalisasi buku BeyondSpring Inc|BYSI - Utang jangka dawa|Utang jangka cendhak perusahaan BeyondSpring|Indikator likuiditas cepet beyondspringpharma.com
- data bathi bisnis lan rasio investasi:
BYSI - Penghasilan resik perusahaan|Bathi mangsa ngarep BeyondSpring Inc.|BYSI - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi BeyondSpring Inc.|BYSI - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA BeyondSpring Inc|BYSI - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) BeyondSpring|BYSI - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan beyondspringpharma.com|BYSI - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep BeyondSpring Inc.
Ringkesan analitik perusahaan:BYSI (BeyondSpring Pharma)
The investment attractiveness of BeyondSpring Inc. (BYSI) is based on the supply of neutropenia drugs to clinics and insurance funds. This metric compares the total enterprise value, including debt, with operating profit before taxes and amortization, allowing for an assessment of the real value of assets. Analyzing the EV/EBITDA trend for BeyondSpring Inc. helps determine the fundamental resilience of the business to its credit load.
Analisis pesaing
Incyte Corp. - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai bisnis marang bathi operasional sadurunge panyusutan HCM|NUVB - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan dayonebio.com|Monopar Therapeutics Inc. (MNPR) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi operasional sadurunge panyusutan INBX|IMAB (I-Mab Biopharma Co., Ltd.) - Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Fennec (FENC)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Heron Therapeutics (HRTX)|NVCT - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Coherus BioSciences Inc. CHRS|Corbus Pharmaceuticals Holdings, Inc. - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|CRDF - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioAtla, Inc.|LIXT: Pangali EV/EBITDA|Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Citius Pharmaceuticals, Inc. CTXR|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CLRB|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioLineRx Ltd BLRX|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CANF (Can-Fite BioPharma, Ltd.)|APRE (aprea.com) - Nilai bisnis marang bathi operasional sadurunge panyusutan|Kazia Therapeutics Limited - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan SLXN (Silexion Therapeutics Corp.)|NuCana Corp - Pangali EV/EBITDA|Nilai bisnis marang bathi operasional sadurunge panyusutan CMRX (Chimerix Inc.)|CYCC: Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan G1 Therapeutics (GTHX)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Kronos Bio, Inc.|KTRA: Nilai bisnis marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA ONCT|Pangali EV/EBITDA Portage Biotech Inc (PRTG)
